PRDM16 and cancer: This enhanced inflammatory status or pro-inflammatory profile of the tumor microenvironment has been shown to contribute to increased lipolysis and cancer cachexia in variable types of cancers through PRDM16 gene overexpression via activation of the STAT3 pathway [29,30].